Shaik Barak Tulla joins Sun Pharma as Senior Vice President and Head of Acute Clusters Ruchika Sharma9 April 2025 7:04 PM ISTSun Pharma has appointed Shaik Barak Tulla as the new Senior Vice President and Head of Acute Clusters. The industry veteran brings with him over 25...
Present relevant data about dose in patient: CDSCO Panel Tells Cipla on FDC of Torsemide Plus Spironolactone 5mg/25 mg Dr. Divya Colin30 March 2025 6:00 PM ISTNew Delhi: Citing that the data/literature presented by the drug major Cipla for the fixed-dose combination (FDC) drug Torsemide and Spironolactone (5...
Cipla gets exclusive rights to market ophthalmic drug across 11 countries Ruchika Sharma20 March 2025 1:30 PM ISTAPP13007 is a novel, patent protected and USFDA approved ophthalmic product.
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIA Farhat Nasim24 Feb 2025 5:12 PM ISTVonoprazan-based GI drugs led new launches, generating Rs 187 crore from 404 brands.
USFDA issues 2 observations for Cipla arm Mahape facility Ruchika Sharma21 Feb 2025 1:30 PM ISTMumbai: Cipla, an Indian multinational pharmaceutical company, has announced that the United States Food and Drugs Administration...
Cipla bags USFDA nod for chronic myeloid leukemia drug Nilotinib Ruchika Sharma21 Feb 2025 11:30 AM ISTMumbai: Pharma major, Cipla, has received final approval from the United States Food and Drug Administration (USFDA) for the New Drug...
Cipla completes investment of ZAR 900 million in South Africa subsidiary Ruchika Sharma19 Feb 2025 4:56 PM ISTMumbai: Cipla Limited has announced that the Company has completed an investment of approx. ZAR 900 million in Cipla Medpro South Africa...
NPPA Fixes Prices of 42 Popular Drugs Including Empagliflozin & Metformin, Dapagliflozin & Glimepiride; Details Farhat Nasim12 Feb 2025 8:31 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 42 essential drugs,...
Indian Pharma Market Sees 8.7% Growth in January 2025, But Vaccines, Ophthalmology Struggle Farhat Nasim10 Feb 2025 6:47 PM ISTNew Delhi: The Indian pharmaceutical market (IPM) recorded an 8.7% year-on-year (YoY) growth in January 2025, reaching a monthly value of Rs 19,238...
Cipla gets VAI status for Virgonagar facility Ruchika Sharma8 Feb 2025 1:30 PM ISTMumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the inspection at the Company’s manufacturing...
Cipla to invest ZAR 900 million in equity share capital of South Africa subsidiary Ruchika Sharma4 Feb 2025 12:30 PM ISTMumbai: Cipla has announced that the Company will invest approx. ZAR 900 million in equity share capital of Cipla Medpro South Africa Proprietary...
Cipla elevates Achin Gupta as new Global Chief Operating Officer Ruchika Sharma29 Jan 2025 1:16 PM ISTMumbai: Cipla has announced the appointment of Achin Gupta, Chief Executive Officer - One India Business (SMP) as the Global Chief Operating Officer...
